<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AND CONDENSED STATEMENT OF OPERATIONS AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000817161
<NAME> ALARIS MEDICAL, INC.
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 29,806
<SECURITIES> 0
<RECEIVABLES> 79,994
<ALLOWANCES> (2,560)
<INVENTORY> 68,346
<CURRENT-ASSETS> 204,546
<PP&E> 131,171
<DEPRECIATION> (69,779)
<TOTAL-ASSETS> 572,621
<CURRENT-LIABILITIES> 96,685
<BONDS> 505,111
0
0
<COMMON> 593
<OTHER-SE> (37,925)
<TOTAL-LIABILITY-AND-EQUITY> 572,621
<SALES> 275,088
<TOTAL-REVENUES> 275,088
<CGS> 149,123
<TOTAL-COSTS> 149,123
<OTHER-EXPENSES> 103,970
<LOSS-PROVISION> (217)
<INTEREST-EXPENSE> (43,648)
<INCOME-PRETAX> (17,210)
<INCOME-TAX> (4,300)
<INCOME-CONTINUING> (12,910)
<DISCONTINUED> 531
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (12,379)
<EPS-BASIC> (.21)
<EPS-DILUTED> (.21)
</TABLE>